Ann: Successful OrthoATI clinical trial, page-18

Great results as expected. I thought might have been released with a bit more fanfare and trading halt to build some suspense. But it seems the information was out well and truly last week so i guess no point.

Quick pat on the back to occ but they really need to turn this into commercially available treatment sooner rather than later. Getting fda approval wont be a walk in the park but certainly achievable. I'm glad no partnership with jnj yet. We aren't approved so don't have great leverage position in a deal and if i was jnj would be wanting approvals before making any deals. Im sure they have each other on speed dial but still a couple of years work to bring it to market in my opinion.